|
|
|
| Clinical study of 34 cases of Chlanmydia pneumonia |
| QIN Ming, JI Chun-Zhen, KUANG Yu-Lian |
|
|
|
|
Abstract No abstract available
|
|
|
|
|
|
| Cite this article: |
|
QIN Ming,JI Chun-Zhen,KUANG Yu-Lian. Clinical study of 34 cases of Chlanmydia pneumonia[J]. 中国当代儿科杂志, 2001, 3(5): 561-562.
|
|
|
|
|
QIN Ming,JI Chun-Zhen,KUANG Yu-Lian. Clinical study of 34 cases of Chlanmydia pneumonia[J]. CJCP, 2001, 3(5): 561-562.
|
| URL: |
| http://www.zgddek.com/EN/ OR http://www.zgddek.com/EN/Y2001/V3/I5/561 |
| [1] |
XIAO Tian-Tian, JIN Mei, JU Rong, YANG Sheng, GAO Shu-Qiang, JIANG Yan, ZHANG Xiao-Long. Value of bedside lung ultrasound in the diagnosis of neonatal pneumonia[J]. CJCP, 2018, 20(6): 444-448. |
| [2] |
CAO Li-Jie, LIU Jian-Hua, SHUAI Jin-Feng, NIU Bo, LU Su-Kun, HUANG Kun-Ling. Efficacy of early treatment via fiber bronchoscope in children with Mycoplasma pneumoniae pneumonia complicated by airway mucus obstruction[J]. CJCP, 2018, 20(4): 298-302. |
| [3] |
CHEN Qi-Fen, ZHANG Yi-Wei. Clinical effect of Saccharomyces boulardii powder combined with azithromycin sequential therapy in treatment of children with diarrhea secondary to Mycoplasma pneumoniae pneumonia[J]. CJCP, 2018, 20(2): 116-120. |
| [4] |
HU Nan, LI Qu-Bei, ZOU Shan-Ye. Effect of vitamin A as an adjuvant therapy for pneumonia in children: a Meta analysis[J]. CJCP, 2018, 20(2): 146-153. |
| [5] |
XU Jiang-Jiang, SHU Lin-Hua. Clinical characteristics of refractory Mycoplasma pneumoniae pneumonia in children[J]. CJCP, 2018, 20(1): 37-42. |
| [6] |
LU Yun-Yun, LUO Rong, FU Zhou. Pathogen distribution and bacterial resistance in children with severe community-acquired pneumonia[J]. CJCP, 2017, 19(9): 983-988. |
| [7] |
LIU Jin, YAN Hong, CHEN Xiao-Geng, MU Ya-Ping. Effects of Huaiqihuang granules on immune function in children with severe Mycoplasma pneumoniae pneumonia[J]. CJCP, 2017, 19(7): 759-762. |
| [8] |
SHEN Dong-Dong, YUAN Fei, HOU Jiang-Hong. Effect of annexin A2 on EGFR/NF-κB signal transduction and mucin expression in human airway epithelial cells treated with Mycoplasma pneumoniae[J]. CJCP, 2017, 19(7): 820-825. |
| [9] |
ZHANG Jing, CUI Ya-Li, JIANG Yong-Mei. Immunoprotective effect of combined pneumococcal endopeptidase O and pneumococcal surface adhesin A vaccines against Streptococcus pneumoniae infection[J]. CJCP, 2017, 19(5): 583-589. |
| [10] |
MA Wei-Yin, PENG Shao, ZHANG Ting. Changes in serum YKL-40 level and humoral immune function and their significance in children with recurrent pneumonia[J]. CJCP, 2017, 19(4): 425-429. |
| [11] |
GUO Xiao-Hui, SUN Yan-Feng, WANG Jiang-Bo, HAN Shu-Zhen, MIAO Jing, CUI Min. Value of nutritional risk screening in evaluating adverse clinical outcomes in children with severe pneumonia[J]. CJCP, 2017, 19(3): 322-326. |
| [12] |
HUANG Miao, LUO Rong, FU Zhou. Risk factors for poor prognosis in children with severe adenovirus pneumonia[J]. CJCP, 2017, 19(2): 159-162. |
| [13] |
ZHANG Hui-Fen, BAI Hai-Tao, LI Ji-Ming, XIE Hui, WANG Ye. Association of drug resistance of Mycoplasma pneumoniae with DNA load and genotypes in children with Mycoplasma pneumoniae pneumonia[J]. CJCP, 2017, 19(11): 1180-1184. |
| [14] |
SHANG Yan-Ping, LIN Li, LI Chang-Chong. Streptococcus pneumoniae induces SPLUNC1 and the regulatory effects of resveratrol[J]. CJCP, 2017, 19(1): 111-116. |
| [15] |
FAN Juan, CHEN Zhi-Ying, CHEN Peng-Yuan, CHEN Chang-Hui. Application of ultrasonic cardiac output monitor in evaluation of cardiac function in children with severe pneumonia[J]. CJCP, 2016, 18(9): 817-820. |
|
|
|
|
